Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2201–2250 of 76231
On May 28, 2026, Raphael Thomas Wallander resigned as a Class III director and member of the Human Capital Management and Compensation Committee of the board of directors (the "Board") of Beyond Meat, Inc. (the "Company").
On June 3, 2026, NextDecade Corporation (the “ Company ”) announced the appointment of John Zuklic as the Chief Financial Officer of the Company, effective July 6, 2026.
the board of directors (the "Board") of Aether Holdings, Inc. (the "Company") appointed Hon Nam Lee (Alvars) as an independent director of the Company to fill a newly created directorship
Stuart Frankel was appointed to the Board.
the Board of Directors (the "Board") of comScore, Inc. (the "Company") appointed Matt McLaughlin as Chief Executive Officer of the Company.
the Company's former CEO, Jon Carpenter, transitioned to a senior advisor position and stepped down from the Board
On June 1, 2026, Marshall S. (“Mackie”) McCrea, III, Co-Chief Executive Officer of Energy Transfer LP (the “Partnership”), notified the Partnership of his intention to retire, effective on or before December 31, 2026.
Upon Mr. McCrea’s retirement, Thomas E. Long, the Partnership’s Co-Chief Executive Officer, will assume the role of sole Chief Executive Officer.
Mr. Stutz will assume the role of Interim Chief Executive Officer effective June 30, 2026.
Effective May 30, 2026, Ms. Owen resigned as a member of the Board and as an officer of the Company and commenced a leave of absence.
On June 1, 2026, MillerKnoll, Inc. (the “Company”) announced that its Board of Directors (the “Board”) and Andi R. Owen, the Company’s President and Chief Executive Officer, have mutually agreed that Ms. Owen will retire from the Company effective June 30, 2026.
Effective May 29, 2026, Ramesh Ramachandran, CPA, MBA, CMA, resigned as the Chief Accounting Officer of Ocugen, Inc.
on June 3, 2026, Rita Johnson-Greene, MBA, the Company’s Chief Financial Officer, was appointed as the Company’s principal accounting officer.
On May 28, 2026, Cadrenal Therapeutics, Inc. (the "Company") and Matthew K. Szot mutually agreed to his transition from the role of Chief Financial Officer, effective May 28, 2026.
Effective immediately after Mr. Szot's termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Principal Accounting Officer, to serve until a permanent Chief Financial Officer is appointed.
On May 28, 2026, in connection with the IPO, Mihir Dange, Gilbert H. Dunham, Jr., Andrew Oakley, and Mattia Tomba were appointed to the board of directors of the Company
Sukhvinder Gill was appointed as Chief Financial Officer, in addition to his existing roles as Chief Operating Officer and Director of the Company
On May 28, 2026, in connection with the IPO, Mihir Dange, Gilbert H. Dunham, Jr., Andrew Oakley, and Mattia Tomba were appointed to the board of directors of the Company
On May 28, 2026, in connection with the IPO, Mihir Dange, Gilbert H. Dunham, Jr., Andrew Oakley, and Mattia Tomba were appointed to the board of directors of the Company
Effective May 28, 2026, Timothy Ramdeen was appointed as Chairman of the Board, in addition to his existing roles as Chief Executive Officer and Director of the Company
On May 28, 2026, in connection with the IPO, Mihir Dange, Gilbert H. Dunham, Jr., Andrew Oakley, and Mattia Tomba were appointed to the board of directors of the Company
Mr. Delzanno and Ms. DeCotis were not nominated for re-election at the Annual Meeting.
Mr. Delzanno and Ms. DeCotis were not nominated for re-election at the Annual Meeting.
each of the following directors of the Company resigned as a member of the Company’s board of directors, effective as of the Effective Time: Ronald G. Lehman II, Richard E. Turk, Jessica Maher and Robert M. Carrino.
each of the following directors of the Company resigned as a member of the Company’s board of directors, effective as of the Effective Time: Ronald G. Lehman II, Richard E. Turk, Jessica Maher and Robert M. Carrino.
each of the following directors of the Company resigned as a member of the Company’s board of directors, effective as of the Effective Time: Ronald G. Lehman II, Richard E. Turk, Jessica Maher and Robert M. Carrino.
each of the following directors of the Company resigned as a member of the Company’s board of directors, effective as of the Effective Time: Ronald G. Lehman II, Richard E. Turk, Jessica Maher and Robert M. Carrino.
On June 3, 2026, the Company announced that Andrew Del Matto, its Chief Financial Officer, will be retiring effective upon the start of a successor.
Rejji P. Hayes has retired from his positions as CMS Energy and Consumers Energy Company (“Consumers Energy”) executive vice president and chief financial officer, effective June 3, 2026.
Srikanth (Sri) Maddipati, 43, has been appointed to succeed Hayes as CMS Energy and Consumers Energy executive vice president and chief financial officer, effective June 3, 2026.
On June 1, 2026, the Board of Directors of Alaska Air Group, Inc. (the “Company”) appointed G. Michael Sievert to the Company’s board of directors, effective immediately.
David Gansberg is stepping down from his role as a President of Arch effective immediately and will be departing the Company following a distinguished tenure
the expansion of Maamoun Rajeh's role as President. Mr. Rajeh, who currently oversees Arch's Reinsurance and Mortgage segments, will also take on responsibility for Arch's Insurance segment
On June 1, 2026, the Board appointed Admiral Scott Swift, USN (Ret.), to the Board and to the Audit Committee of the Board ( the “Audit Committee”), the Compensation Committee of the Board (the “Compensation Committee”), and the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”).
On June 1, 2026, Ian Charles notified the board of directors (the “Board”) of The Glimpse Group, Inc. (the “Company”), of his resignation as a member of the Board and all committees thereof, effective as of June 1, 2026.
On June 1, 2026, the Board appointed Major General Pete Fesler, USA (Ret.), to the Board and to the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee.
On June 1, 2026, Alexander Ruckdaeschel notified the Board of his resignation as a member of the Board and all committees thereof, effective as of June 1, 2026.
Lyron Bentovim notified the Board of his resignation as the Chairperson and a member of the Board and all committees of the Board, and from his roles as President and Chief Executive Officer of the Company, in each case effective June 15, 2026.
On June 1, 2026, the Board appointed Brian Archer to the Board and to the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee.
On June 1, 2026, the Board appointed Tyler Gates as the Company’s President and Chief Executive Officer and as a director on the Board.
On May 29, 2026, the Board of Directors (the “Board”) of Ovid Therapeutics Inc. (the “Company”) approved, effective as of June 15, 2026, an increase in the size of the Board and, upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), the appointment of Anna Greka, M.D., Ph.D., as a Class III director of the Company, with her term expiring at the Company’s 2029 annual meeting of stockholders.
On June 1, 2026, the Board of Directors (the “ Board ”) of New Era Energy & Digital, Inc. (the “ Company ”) appointed Darin Rovell to serve as Chief Accounting Officer of the Company, effective June 22, 2026.
on June 1, 2026, the Board appointed Luke A. Hewko as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer, effective upon Mr. Croal’s retirement.
On June 1, 2026, Thomas V. Croal notified GEN Restaurant Group, Inc. (the “Company”) of his decision to retire from his position as Chief Financial Officer, Secretary, principal financial officer and principal accounting officer of the Company, effective at the close of business on June 1, 2026.
Wade Lyall as Chief Sales Officer of the Company, John Kastanek as Chief Customer Experience Officer of the Company, and Andrew Houser as Senior Vice President of Manufacturing of the Company.
On June 1, 2026, Joseph Kimmell, Executive Vice President, Operations of Champion Homes, Inc. (the “Company”), notified the Company of his decision to retire from such position effective June 26, 2026 (the “Effective Date”).
Wade Lyall as Chief Sales Officer of the Company, John Kastanek as Chief Customer Experience Officer of the Company, and Andrew Houser as Senior Vice President of Manufacturing of the Company.
Wade Lyall as Chief Sales Officer of the Company, John Kastanek as Chief Customer Experience Officer of the Company, and Andrew Houser as Senior Vice President of Manufacturing of the Company.
On June 1, 2026, the Board appointed Marc Beer as Executive Chairman of the Board, effective June 8, 2026.
On May 27, 2026, the Board of Directors (the “Board”) of biote Corp. (the “Company”) accepted the resignation of Bret Christensen, the Company’s Chief Executive Officer, from his position as Chief Executive Officer of BioTE Medical, LLC (“BioTE”), effective as of June 8, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.